The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
Open accessAbstract
The c-abl proto-oncogene encodes a cytoplasmic tyrosine kinase which is homologous to the src gene product in its kinase domain and in the upstream kinase regulatory domains SH2 (src homology region 2) and SH3 (src homology region 3). The murine v-abl oncogene product has lost the SH3 domain as a consequence of N-terminal fusion of gag sequences. Deletion of the SH3 domain is sufficient to render the murine c-abl proto-oncogene product transforming when myristylated N-terminal membrane localization sequences are also present. In contrast, the human BCR/ABL oncogene of the Philadelphia chromosome translocation has an intact SH3 domain and its product is not myristylated at the N terminus. To analyze the contribution of BCR-encoded sequences to BCR/ABL-mediated transformation, the effects of a series of deletions and substitutions were assessed in fibroblast and hematopoietic-cell transformation assays. BCR first-exon sequences specifically potentiate transformation and tyrosine kinase activation when they are fused to the second exon of otherwise intact c-ABL. This suggests that BCR-encoded sequences specifically interfere with negative regulation of the ABL-encoded tyrosine kinase, which would represent a novel mechanism for the activation of nonreceptor tyrosine kinase-encoding proto-oncogenes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
Takebe, Y., Seiki, M., Fujisawa, J.-I., Hoy, P., Yokota, K., Arai, K.-I., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Self-citationA human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martin-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 803
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
Ellis, C., Moran, M., McCormick, F., & Pawson, T. (1990) · Nature · doi:10.1038/343377a0 · Cited by 746
A novel viral oncogene with structural similarity to phospholipase C
Mayer, B. J., Hamaguchi, M., & Hanafusa, H. (1988) · Nature · doi:10.1038/332272a0 · Cited by 735
Acute leukaemia in bcr/abl transgenic mice
Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 672
Requirement for c-ras proteins during viral oncogene transformation
Smith, M. R., DeGudicibus, S. J., & Stacey, D. W. (1986) · Nature · doi:10.1038/320540a0 · Cited by 621
Long-term culture of B lymphocytes and their precursors from murine bone marrow.
Whitlock, C. A., & Witte, O. N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3608 · Cited by 571
Self-citationSadowski, I., Stone, J. C., & Pawson, T. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4396 · Cited by 530
Sequence similarity of phospholipase C with the non-catalytic region of src
Stahl, M. L., Ferenz, C. R., Kelleher, K. L., Kriz, R. W., & Knopf, J. L. (1988) · Nature · doi:10.1038/332269a0 · Cited by 515
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Kelliher, M. A., McLaughlin, J., Witte, O. N., & Rosenberg, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6649 · Cited by 514
Self-citationExpression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.
Hall, C. V., Jacob, P. E., RINGOLD, G. M., & Lee, F. (1983) · PubMed · Cited by 472
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 464
McLaughlin, J., Chianese, E., & Witte, O. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6558 · Cited by 367
Self-citationSefton, B. M., Trowbridge, I. S., Cooper, J. A., & Scolnick, E. M. (1982) · Cell · doi:10.1016/0092-8674(82)90139-8 · Cited by 352
Elefanty, A. G., Hariharan, I. K., & Cory, S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08212.x · Cited by 344
Rein, A., McClure, M. R., Rice, N. R., Luftig, R. B., & Schultz, A. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7246 · Cited by 297
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
Jackson, P., & Baltimore, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03397.x · Cited by 278
A tail of two src's: Mutatis mutandis
Hunter, T. (1987) · Cell · doi:10.1016/0092-8674(87)90745-8 · Cited by 276
Alternative 5′ exons in c-abl mRNA
Ben-Neriah, Y., Bernards, A., Paskind, M., Daley, G. Q., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90267-9 · Cited by 266
Konopka, J. B., & Witte, O. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3116 · Cited by 250
Self-citationPawson, T. J. (1988) · PubMed · Cited by 243
Franz, W. M., Berger, P., & Wang, J. Y. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03358.x · Cited by 202
High frequency of aberrant expression of moloney murine leukemia virus in clonal infections
Shields, A., Witte, O. N., Rothenberg, E., & Baltimore, D. (1978) · Cell · doi:10.1016/0092-8674(78)90245-3 · Cited by 176
Self-citationThe BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
Lugo, T. G., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1263 · Cited by 172
Self-citationThe CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 Fibroblasts
Daley, G. Q., McLaughlin, J., Witte, O. N., & Baltimore, D. (1987) · Science · doi:10.1126/science.2440107 · Cited by 172
Self-citationKato, J. Y., Takeya, T., Grandori, C., Iba, H., Levy, J. B., & Hanafusa, H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4155 · Cited by 164
Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation
Prywes, R., Foulkes, J. G., Rosenberg, N. E., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90389-6 · Cited by 164
Hirai, H., & VARMUS, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1307 · Cited by 151
Kirschmeier, P. T., Housey, G. M., Johnson, M. D., Perkins, A. S., & Weinstein, I. B. (1988) · DNA · doi:10.1089/dna.1988.7.219 · Cited by 151
the Viral and Cellular Forms of the Abelson (Dbl) Oncogene
Rosenberg, N. E., & Witte, O. N. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60708-3 · Cited by 150
Self-citationTransfected DNA Is Mutated in Monkey, Mouse, and Human Cells
LEBKOWSKI, J. S., DuBridge, R. B., Antell, E. A., Greisen, K. S., & Calos, M. P. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.10.1951-1960.1984 · Cited by 147
McLaughlin, J., Chianese, E., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.1866 · Cited by 144
Self-citationIdentification of a nucleotide exchange-promoting activity for p21ras.
Downward, J., Riehl, R., Wu, L., & Weinberg, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5998 · Cited by 142
Mes‐Masson, A., McLaughlin, J., Daley, G. Q., Paskind, M. P., & Witte, O. N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9768 · Cited by 124
Self-citationHamaguchi, M., Grandori, C., & Hanafusa, H. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3035 · Cited by 122
Lethal effect of the abelson murine leukemia virus transforming gene product
Ziegler, S. F., Whitlock, C. A., Goff, S. P., Gifford, A. M., & Witte, O. N. (1981) · Cell · doi:10.1016/0092-8674(81)90389-5 · Cited by 97
Self-citationPotts, W. M., Reynolds, A. B., Lansing, T. J., & Parsons, J. T. (1988) · PubMed · Cited by 85
Watanabe, S. M., & Witte, O. N. (1983) · Journal of Virology · doi:10.1128/jvi.45.3.1028-1036.1983 · Cited by 53
Self-citationNucleotide sequence analysis of human abl and bcr-abl cDNAs.
Fainstein, E., Einat, M., Gokkel, E., Marcelle, C., Croce, C. M., Gale, R. P., & Canaani, E. (1989) · PubMed · Cited by 49
Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules
Schiff-Maker, L., Burns, M. C., Konopka, J. B., Clark, S., Witte, O. N., & Rosenberg, N. E. (1986) · Journal of Virology · doi:10.1128/jvi.57.3.1182-1186.1986 · Cited by 46
Self-citationNucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert
Bergold, P. J., Blumenthal, J. A., D'Andrea, E., Snyder, H. W., Lederman, L., Silverstone, A. E., Nguyen, H. N., & Besmer, P. (1987) · Journal of Virology · doi:10.1128/jvi.61.4.1193-1202.1987 · Cited by 29
Cited by
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Wang, X., & Ron, D. (1996) · Science · doi:10.1126/science.272.5266.1347 · Cited by 883
Rice, J. C., Briggs, S. D., Ueberheide, B., Barber, C. M., Shabanowitz, J., Hunt, D. F., Shinkai, Y., & Allis, C. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00479-9 · Cited by 825
Metadata
- Authors
- Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1991-04
- Volume
- 11
- Issue
- 4
- Pages
- 1785-1792
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2124132224
- Cited by
- 377
- References
- 48
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.